Related Experiment Video
Updated: Jul 1, 2025

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
The NIH-Moderna Vaccine: Public Science, Private Profit, and Lessons for the Future
The National Institutes of Health-Moderna COVID-19 vaccine
Area of Science:
- Vaccinology
- Pharmaceutical Policy
- Public Health
Background:
- The development of the National Institutes of Health-Moderna COVID-19 vaccine involved significant public investment and research.
- Concerns exist regarding the private capture of publicly funded biomedical innovations.
- Governmental policy decisions have influenced pharmaceutical development and access.
Purpose of the Study:
- To examine the scientific history and public-private dynamics of the NIH-Moderna COVID-19 vaccine.
- To analyze policy missteps by recent US administrations concerning vaccine development.
- To propose policy recommendations for equitable pharmaceutical development and manufacturing.
Main Methods:
- Historical analysis of vaccine development milestones.
- Review of public funding and private sector involvement.
- Policy analysis of governmental actions and contract structures.
Main Results:
- Public investment played a crucial role in the NIH-Moderna COVID-19 vaccine's creation.
- Instances of private entities capturing value generated by public research were identified.
- Both the Trump and Biden Administrations exhibited policy shortcomings in managing vaccine development and distribution.
Conclusions:
- There is a need for improved contract negotiation and incentive structures with pharmaceutical manufacturers.
- A not-for-profit public option for pharmaceutical development could enhance public benefit.
- Policy reforms are essential to ensure equitable access and value from public investments in medical innovation.
More Related Videos
10:16Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
Related Concept Videos
Vaccinations
What is Genetic Engineering?
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Steps in Outbreak Investigation
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...